Tyra Biosciences, Inc.TYRA
Price (close)
$22.41
Market cap
$1.3B
P/E
—
Revenue (TTM)
—
Net income
-$148.6M
Dividend yield
—
1-year total return
78.7%
Net margin
—
Revenue growth
—
Debt / equity
—
What Tyra Biosciences, Inc. does.
No business description on file yet.
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Net income | -$9.3M | -$26.3M | -$55.3M | -$69.1M | -$86.5M | -$119.9M |
| Free cash flow | -$8.1M | -$24.4M | -$50.8M | -$50.9M | -$70.4M | -$95.3M |
More on TYRA.
- Tyra Biosciences, Inc. summary
- Tyra Biosciences, Inc. financial statements
- Tyra Biosciences, Inc. key metrics
- Tyra Biosciences, Inc. health scores and style box
- Tyra Biosciences, Inc. earnings
- Tyra Biosciences, Inc. dividends
- Tyra Biosciences, Inc. valuation
- Tyra Biosciences, Inc. ownership and insiders
- Tyra Biosciences, Inc. peers
Figures from Tyra Biosciences, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.